Phase 1 Study of Venetoclax in Combination With Decitabine 10-Day Regimen in Subjects With Acute Myeloid Leukemia
Latest Information Update: 18 Mar 2026
At a glance
- Drugs Decitabine (Primary) ; Venetoclax (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
Most Recent Events
- 04 Mar 2026 Planned End Date changed from 10 Dec 2025 to 10 Dec 2027.
- 04 Mar 2026 Planned primary completion date changed from 10 Dec 2025 to 10 Dec 2027.
- 01 Oct 2025 Planned End Date changed from 10 Jun 2025 to 10 Dec 2025.